Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
ESMO Open|June 5, 2024
An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202A Vogel, V Sahai, A Hollebecque, et al.
The Lancet. Oncology|March 24, 2020
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 studyGhassan K Abou-Alfa, Vaibhav Sahai, Antoine Hollebecque, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 5, 2020
ADC measurements on the Unity MR-linac - A recommendation on behalf of the Elekta Unity MR-linac consortiumErnst S Kooreman, Petra J van Houdt, Rick Keesman, et al.
Clinical Breast Cancer|March 20, 2002
Low proliferative rate of invasive node-negative breast cancer predicts for a favorable outcome: a prospective evaluation of 669 patientsS Jones, G Clark, S Koleszar, et al.
The Lancet. Oncology|May 4, 2023
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 studyJohn H Strickler, Andrea Cercek, Salvatore Siena, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2019
The transformation of radiation oncology using real-time magnetic resonance guidance: A reviewWilliam A Hall, Eric S Paulson, Uulke A van der Heide, et al.
Medical Physics|July 7, 2021
Findings of the AAPM Ad Hoc committee on magnetic resonance imaging in radiation therapy: Unmet needs, opportunities, and recommendationsKiaran P McGee, Neelam Tyagi, John E Bayouth, et al.
Pageof 12